- Home
- ITCI vs KT Comparison
ITCI vs KT Comparison
Compare ITCI & KT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- KT
- Stock Information
- Founded
- ITCI 2002
- KT 1981
- Country
- ITCI United States
- KT South Korea
- Employees
- ITCI N/A
- KT N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- KT Telecommunications Equipment
- Sector
- ITCI Health Care
- KT Telecommunications
- Exchange
- ITCI Nasdaq
- KT Nasdaq
- Market Cap
- ITCI 8.0B
- KT 9.0B
- IPO Year
- ITCI N/A
- KT 1999
- Fundamental
- Price
- ITCI $86.00
- KT $15.97
- Analyst Decision
- ITCI Strong Buy
- KT
- Analyst Count
- ITCI 12
- KT 0
- Target Price
- ITCI $97.67
- KT N/A
- AVG Volume (30 Days)
- ITCI 455.4K
- KT 2.6M
- Earning Date
- ITCI 02-20-2025
- KT 02-10-2025
- Dividend Yield
- ITCI N/A
- KT 4.53%
- EPS Growth
- ITCI N/A
- KT 0.16
- EPS
- ITCI N/A
- KT 3.60
- Revenue
- ITCI $613,728,000.00
- KT $20,141,581,365.00
- Revenue This Year
- ITCI $48.41
- KT $2.80
- Revenue Next Year
- ITCI $38.26
- KT $2.82
- P/E Ratio
- ITCI N/A
- KT $8.60
- Revenue Growth
- ITCI 46.08
- KT 0.74
- 52 Week Low
- ITCI $62.78
- KT $12.10
- 52 Week High
- ITCI $93.45
- KT $18.45
- Technical
- Relative Strength Index (RSI)
- ITCI 54.91
- KT 44.75
- Support Level
- ITCI $82.76
- KT $15.91
- Resistance Level
- ITCI $89.12
- KT $16.48
- Average True Range (ATR)
- ITCI 2.48
- KT 0.27
- MACD
- ITCI -0.04
- KT -0.09
- Stochastic Oscillator
- ITCI 59.75
- KT 34.95
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About KT KT Corporation
KT is South Korea's largest fixed-line telecom operator, with around 11.7 million fixed-line broadband customers and 9.4 million IPTV customers, and is the second-largest wireless operator with 25 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom) KT created its own mobile operator in 1997.